PCI Biotech Stock Forward View - Simple Regression
| PCIB Stock | NOK 0.16 -0.02 -11.11% |
This reference view applies Simple Regression to PCI Biotech Holding's historical closing prices. PCI Biotech Holding's Simple Regression reference page summarizes the forecasted price and model accuracy metrics from daily trading data. PCI Biotech Holding's forecast reference data is generated from the equity's historical trading prices. Mean absolute deviation and related metrics help quantify forecast uncertainty for PCI Biotech Holding.
The Simple Regression forecasted value of PCI Biotech Holding on the next trading day is expected to be 0.18 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.65.In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as PCI Biotech Holding historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data. All forecast values on this page for PCI Biotech Holding are Simple Regression reference data derived from historical price series. Simple Regression Price Forecast For the 25th of March
Given 90 days horizon, the Simple Regression forecasted value of PCI Biotech Holding on the next trading day is expected to be 0.18 with a mean absolute deviation of 0.03 , mean absolute percentage error of 0.0014 , and the sum of the absolute errors of 1.65 .Please note that although there have been many attempts to predict PCI Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that PCI Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest PCI Biotech | PCI Biotech Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for PCI Biotech Holding uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. At the moment, the model places downside around 0.0016 and upside around 18.34 for the forecasting period.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of PCI Biotech stock data series using in forecasting. Note that when a statistical model is used to represent PCI Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.352 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0266 |
| MAPE | Mean absolute percentage error | 0.1351 |
| SAE | Sum of the absolute errors | 1.6502 |
Other Forecasting Options for PCI Biotech
Volume-weighted price analysis for PCI Stock gives heavier weight to price levels where trading activity was highest. Crossovers in the MACD line and signal line can identify shifts in PCI momentum before they appear in raw price. Comparing PCI Biotech's realized volatility to implied volatility reveals whether the options market expects larger or smaller moves. Readings above 80 or below 20 highlight potential reversal zones in PCI Stock price action.PCI Biotech Related Equities
These firms work in a similar space as PCI Biotech within the Health Care space and serve as useful points for comparison. Checking PCI Biotech against peers on P/E, margins, and return on equity helps put its position in context.
| Risk & Return | Correlation |
PCI Biotech Market Strength Events
Evaluating the market strength of PCI Biotech stock allows investors to gauge shifts in market momentum. Monitoring these indicators highlights periods where PCI Biotech Holding trading conditions shift meaningfully. These metrics are particularly useful when PCI Biotech stock shows divergence from broader market trends. Regularly reviewing PCI Biotech Holding strength signals helps maintain a structured approach to position management.
PCI Biotech Risk Indicators
Understanding PCI Biotech's risk indicators is essential for any investor seeking to forecast its future price accurately. By identifying how much risk is embedded in PCI Biotech's investment, investors can decide how to position their exposure. Reviewing PCI Biotech's basic risk indicators is essential for managing investment risk effectively. The risk-return trade-off for pci stock becomes clearer when PCI Biotech's risk indicators are properly assessed.
| Mean Deviation | 8.57 | |||
| Semi Deviation | 9.74 | |||
| Standard Deviation | 17.2 | |||
| Variance | 295.93 | |||
| Downside Variance | 179.7 | |||
| Semi Variance | 94.82 | |||
| Expected Short fall | -18.20 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for PCI Biotech
Story coverage around PCI Biotech Holding often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. A disciplined read of coverage separates durable relevance from temporary noise.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
PCI Biotech Short Properties
A short-interest review of PCI Biotech Holding provides context for understanding whether skepticism in the market is becoming more influential. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 115.2 M |
More Resources for PCI Stock Analysis
Other Information on Investing in PCI Stock
Financial ratios for PCI Biotech show relationships between important financial metrics. They provide context across profit, cash flow, and overall value.